TIAA CREF Investment Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	$152K	Hold	754	–	–	﹤0.01%	2919
2018 Q4	$141K	Hold	754	–	–	﹤0.01%	2925
2018 Q3	$180K	Sell	754 -246	-25%	-$58.7K	﹤0.01%	3002
2018 Q2	$265K	Buy	+1,000	New	+$265K	﹤0.01%	2982